Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Merck

Vaccines using mRNA can protect farm animals against diseases traditional ones may not – and there are safeguards to ensure they won't end up in your food

While effective vaccines for COVID-19 should have heralded the benefits of mRNA vaccines, fear and misinformation about their supposed dangers circulated at the same time. These misconceptions about mRNA vaccines have recently spilled over into worries about whether their use in agricultural animals could expose people to components of the…

The Conversation

1 Pharma Stock You'll Regret Not Buying Earlier

The long-term prospects of Merck (MRK) look bright due to its latest acquisitions and solid drug pipeline. Therefore, investing in this stock could help generate substantial returns in the long run. Keep reading….

StockNews.com

Stocks Close Mildly Higher on Q1 Earnings Optimism

What you need to know… The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.33%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.30%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.06%. Stock indexes Monday posted moderate gains. An increase in...

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Stocks Undercut by Higher Bond Yields and Weakness in Chip Stocks

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is up +0.05%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.23%. U.S. stock indexes this morning are mixed. An increase...

Barchart

Markets Today: Stock Index Futures Mixed on Pressure from Higher Bond Yields

Morning Markets June S&P 500 futures (ESM2 3) this morning are up +0.02%, and June Nasdaq 100 E-Mini futures (NQM2 3) are down -0.03%. U.S. stock index futures this morning are mixed. An increase in M&A activity is positive for stocks after Merck said it would acquire Prometheus Biosciences for...

Barchart

Study: Vaccine helps drug keep melanoma patients cancer-free

Adding a personalized cancer vaccine to the blockbuster drug Keytruda kept more melanoma patients in remission than the immune therapy alone, co-developers Moderna Inc. and Merck & Co. said in their first detailed presentation of a key study.

Tribune News Service

Does the future of medicine lie in space?

Earth’s gravity makes it harder to cultivate the proteins needed to study diseases and pathogens. And although the cost of space travel is high, private enterprise is stepping in

The Guardian - UK

Read news from The Economist, FT, and more,
with one subscription

Insurance Agencies Would Love to Know Who Blew Up Nord Stream

An era of gray zone warfare and sabotage creates tough financial questions.

Foreign Policy

Pfizer buys biotech firm Seagen for $43 billion

WASHINGTON - US pharmaceutical giant Pfizer announced Monday that it had reached a deal to buy biotech firm Seagen, specializing in innovative cancer treatment, for $43 billion.

Bangkok Post

What are these 'cancer vaccines' I'm hearing about? And what similarities do they share with COVID vaccines?

Barely a month goes by without headlines announcing yet another advancement in cancer vaccines.

The Conversation

What are these ‘cancer vaccines’ making news? Are there similarities with COVID vaccines?

Using the same mRNA technology as COVID vaccines, cancer vaccines are an emerging personalised treatment for cancer.

The New Daily

Merck Livingston announces 15 new jobs and £2.6 million investment

Strategic partnership signed with Scottish Enterprise to develop novel quality control kit

Insider UK

The cost of cybersecurity insurance is soaring–and state-backed attacks will be harder to cover. It’s time for companies to take threats more seriously

State-backed attacks are on the rise–and the insurance sector is increasingly excluding them from coverage.

Fortune

Merck COVID drug linked to new virus mutations, study says

Merck & Co.’s COVID-19 pill is giving rise to new mutations of the virus in some patients, according to a study that underscores the risk of trying to intentionally alter the pathogen’s genetic code.

Tribune News Service

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Meet the German shepherd who was the richest dog in the world — and had a huge secret

“Gunther’s Millions”, a new Netflix documentary, investigates the story of Gunther, one in a long line of German Shepherds who had supposedly inherited a fortune from their late owner. Clémence Michallon reports

Daily Mirror

Who is Gunther? Inside hoax claims and secrets of world's richest dog in new Netflix doc

Netflix docuseries Gunther's Millions will explore the 'hoax' surrounding the world's richest dog Gunther and the man who cares for him, businessman Maurizio Mian

The Conversation

Cancer vaccine trials could start in the autumn – UK signs deal with BioNTech

The UK government recently announced that it is partnering with German firm BioNTech to test vaccines for cancer and other diseases. The project aims to build on the mRNA vaccine technology that BioNTech became famous for developing, and which has been so successful at preventing serious illness and death from…

Bangkok Post

Chinese take risks on black-market Covid drugs

BEIJING: Desperate families searching for critical Covid-19 medication in China, faced with bare pharmacy shelves and an explosion of cases, are being driven into murky online marketplaces rife with price gouging and fraud.

Get all your
news in one place.

100's of premium titles.
One news app.

Tribune News Service

Lisa Jarvis: Cancer vaccine hunt makes progress, finally

The long-awaited cancer vaccine revolution is getting a little closer to reality. New data from Moderna Inc. and Merck & Co. suggest that after decades of failures, researchers are finally figuring out the right way to design a vaccine that can teach immune cells how to recognize and combat tumors.

StockNews.com

3 High-Flying Pharma Stocks to Buy Right Now

The healthcare industry is poised to grow significantly in the coming years. Moreover, as healthcare stocks tend to perform relatively well despite macro uncertainties due to inelastic demand for their products and services, high-flying pharma stocks Novo Nordisk (NVO), AbbVie (ABBV), and Merck & Co (MRK) might be ideal investments…

Al Jazeera

Ebola vaccines produced lasting antibodies during trial: Studies

Studies in West Africa said the vaccines developed by Johnson & Johnson and Merck & Co appear to be safe in children.

Reuters

J&J and Merck Ebola vaccines produce lasting antibodies in children and adults -studies

Ebola vaccines developed by Johnson Johnson and Merck Co produced virus-fighting antibodies and appear to be safe in children and adults, according to data from two studies published on Wednesday.

The Independent UK

Cancer vaccine halves risk of relapse or death using Covid jab technology

Jab led to reduction in risk of cancer coming back or death in patients with stage three and four melanoma

Fortune

Skin cancer vaccine trial shows promising results

Moderna and Merck team up in new study.

Mic

Researchers from Moderna and Merck just made a breakthrough with a skin cancer vaccine

Thank you, science.

1 … 7 8 9 10

People

Dipanjan BanchurSince

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.